STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

AKANDA CORP SEC Filings

AKAN Nasdaq

Welcome to our dedicated page for AKANDA SEC filings (Ticker: AKAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking a cross-border cannabis company like Akanda Corp can feel overwhelming—hundreds of pages on cultivation yields, UK CBPM licenses, and blockchain initiatives are scattered across multiple SEC forms. If you have ever searched “Akanda Corp SEC filings explained simply” or wondered why an 8-K material event matters to Portugal greenhouse output, you are not alone.

Stock Titan solves this problem. Our AI instantly turns every 10-K annual report, 10-Q quarterly earnings report, and 8-K update into plain-language insights, flagging the sections regulators watch most. Need Akanda Corp insider trading Form 4 transactions? We stream Form 4 insider transactions in real-time and highlight patterns across executives. Curious about financing for new cultivation rooms? Our dashboard links that disclosure directly to the cash-flow table and offers an Akanda Corp earnings report filing analysis in seconds.

Investors use these tools to:

  • Compare THC-yield trends across quarters without combing spreadsheets in the 10-Q.
  • Monitor Akanda Corp executive stock transactions Form 4 before major licensing news.
  • Review the Akanda Corp proxy statement executive compensation to see how bonuses align with cultivation output.

Whether you are understanding Akanda Corp SEC documents with AI for the first time or double-checking a footnote on Portuguese tax credits, Stock Titan provides complete coverage, real-time alerts, and concise explanations—so you spend more time acting on information and less time digging for it.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.01%
Tags
current report
-
Rhea-AI Summary

Akanda Corp. furnished materials related to its Special Meeting of Shareholders, which was originally scheduled for October 30, 2025 and adjourned to November 28, 2025. The submission includes the notice of the adjourned meeting, the notice and management information circular dated September 29, 2025, and a proxy card.

These documents provide shareholders with the official notices and proxy materials for the rescheduled meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Akanda Corp. reported that its previously announced special meeting of common shareholders, convened on October 30, 2025, achieved a quorum but was adjourned to November 28, 2025. The meeting will reconvene on Friday, November 28, 2025 at 10:00 a.m. (Toronto time) at Gowling WLG (Canada) LLP, Suite 1600, 100 King Street West, Toronto, ON, M5X 1G5.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.69%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.03%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.62%
Tags
current report
-
Rhea-AI Summary

Akanda Corp. filed a Form 6-K reporting a series of risks and corporate developments disclosed to investors. The filing lists numerous business risks including limited operating history, integration and growth of First Towers & Fiber Corp., regulatory and product risks related to cannabis operations, competition, expansion into new jurisdictions, and the ability to raise capital and maintain Nasdaq listing.

Interim financial line items shown in the filing indicate continuing operating losses of $1,404,293 and $2,277,308 (comparative period), and losses from discontinued operations of $815,001 and $2,682,890. The filing also references corporate actions including a share consolidation, First Towers closing, assumption of First Towers indebtedness, a consideration note, a convertible note transaction, an amendment to an option agreement, a consulting agreement with IR Agency LLC and attached interim condensed consolidated financial statements and XBRL exhibits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.7%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of AKANDA (AKAN)?

The current stock price of AKANDA (AKAN) is $1.16 as of November 14, 2025.

What is the market cap of AKANDA (AKAN)?

The market cap of AKANDA (AKAN) is approximately 939.5K.
AKANDA CORP

Nasdaq:AKAN

AKAN Rankings

AKAN Stock Data

939.49k
722.54k
0.8%
1.31%
3.76%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Toronto